103 related articles for article (PubMed ID: 2026237)
1. Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis.
Suter S; Chevallier I
Eur Respir J; 1991 Jan; 4(1):40-9. PubMed ID: 2026237
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
3. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa.
Suter S; Schaad UB; Tegner H; Ohlsson K; Desgrandchamps D; Waldvogel FA
J Infect Dis; 1986 May; 153(5):902-9. PubMed ID: 3486235
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte elastase-mediated proteolysis of alpha 1-antitrypsin in cystic fibrosis bronchopulmonary secretions.
Cantin A; Bilodeau G; Bégin R
Pediatr Pulmonol; 1989; 7(1):12-7. PubMed ID: 2788857
[TBL] [Abstract][Full Text] [Related]
5. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
Hansen G; Hoffjan S; Mosler K; Schuster A
Lung; 2001; 179(3):185-94. PubMed ID: 11891608
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin-cleaving activity in bronchial secretions of patients with cystic fibrosis.
Suter S; Schaad UB; Morgenthaler JJ; Chevallier I; Schnebli HP
J Infect Dis; 1988 Jul; 158(1):89-100. PubMed ID: 3292666
[TBL] [Abstract][Full Text] [Related]
8. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
10. Activity of serum inhibitory proteases in bronchial secretions from children with various chronic non-specific respiratory diseases.
Rudnik J; Kurzawa R; Gawel J; Majewska-Zalewska H; Zebrak J
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):717-22. PubMed ID: 312082
[TBL] [Abstract][Full Text] [Related]
11. The mucosal defence capacity against proteolytic leukocyte enzymes.
Tegner H; Fryksmark U; Ohlsson K
Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
13. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
[TBL] [Abstract][Full Text] [Related]
14. DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.
Ying QL; Simon SR
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):506-13. PubMed ID: 11017916
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
16. Competition between elastase and related proteases from human neutrophil for binding to alpha1-protease inhibitor.
Korkmaz B; Poutrain P; Hazouard E; de Monte M; Attucci S; Gauthier FL
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):553-9. PubMed ID: 15764720
[TBL] [Abstract][Full Text] [Related]
17. Evidence that Pseudomonas aeruginosa elastase does not inactivate the bronchial inhibitor in the presence of leukocyte elastase. Studies with cystic fibrosis sputum and with pure proteins.
Tournier JM; Jacquot J; Puchelle E; Bieth JG
Am Rev Respir Dis; 1985 Sep; 132(3):524-8. PubMed ID: 2412473
[TBL] [Abstract][Full Text] [Related]
18. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1.
Chan SC; Shum DK; Ip MS
Am J Respir Crit Care Med; 2003 Jul; 168(2):192-8. PubMed ID: 12702549
[TBL] [Abstract][Full Text] [Related]
19. The rôle of proteases and antiproteases in bronchial secretions.
Hutchison DC
Eur J Respir Dis Suppl; 1987; 153():78-85. PubMed ID: 2448162
[TBL] [Abstract][Full Text] [Related]
20. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
